Impact of Non-etiological Novel Therapies in the Course of Cirrhosis: Consensus Statements of Panel 4
Crossref DOI link: https://doi.org/10.1007/978-3-031-08552-9_27
Published Online: 2022-10-19
Published Print: 2022
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Albillos, AgustÃn
Trebicka, Jonel
Bajaj, Jasmohan S.
Krag, Aleksander
Laleman, Wim
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-01-01
Chapter History
First Online: 19 October 2022